Showing results (1-10 of 568) with videos related to
Sort By:
Pageof 57
The Urologic Clinics of North America|July 12, 2002
PC-SPES and prostate cancerWilliam K Oh, Eric J SmallSeminars in Oncology|January 8, 2003
Complementary and alternative therapies in prostate cancerWilliam K Oh, Eric J SmallCancer|December 12, 2003
A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813William K Oh, Susan Halabi, W Kevin Kelly, et al.Cancer|December 6, 2005
A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapyJonathan E Rosenberg, Matthew D Galsky, Nicholas C Rohs, et al.Cancer Cell|July 12, 2017
Redefining Hormonal Therapy for Advanced Prostate Cancer: Results from the LATITUDE and STAMPEDE StudiesEric J SmallJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2008
Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatmentLawrence Fong, Eric J SmallExpert Review of Anticancer Therapy|May 24, 2017
Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatmentArchana Anantharaman, Eric J SmallPageof 57